BioMark Diagnostics at the equities.com Small-Cap Stars Conference at the NASDAQ MarketSite
We appreciate the opportunity speaking with BioMark Diagnostics at the equities.com Small-Cap Stars Conference at the NASDAQ MarketSite and to learn more about BioMark Diagnostics. Here is the link to your video interview: http://www.equities.com/media-gallery/384-brian-gusko-dir-of-corp-relations-for-biomark-diagnostics-bux?category_id=74
Biomark Diagnostics Develops Cancer Diagnostics Kit
Published by Canadian Investor on December 9, 2014 A newly listed company, Biomark Diagnostics, is making headlines with their cancer diagnostic technology, which is currently in Phase 3 clinical trials. The technology will enable patients to receive a non-invasive test for the diagnosis of many cancers. The Company’s patents and technology calls for the […]
Wolverton Securities advisor believes in biotechnology
Santo Sandhu, an investment advisor with Wolverton Securities, said he believes the best opportunities right now lie in biotechnology. That has led him to BioMark Diagnostics Inc., a Richmond B.C. company that is developing a cancer diagnostic system, using a known drug, which has already been approved by the U.S. Federal Drug Administration and Health […]
Dr. JOHN YOO JOINS BIOMARK ADVISORY TEAM
Vancouver, British Columbia – (November 17th, 2014) –BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) is pleased to announce that it has appointed Dr. John Yoo to its clinical advisory team. Dr. Yoo is the Professor and Chair, City-Wide Chief, Department of Otolaryngology-Head and Neck Surgery and Professor in the Department of Oncology at the Schulich School […]
SUN NEWS: Lung Cancer Deadliest in North America
Lung cancer is the deadliest cancer in North America, killing twice as many Canadians as any other cancer. SPECIAL REPORT Watch Video Here: http://www.sunnewsnetwork.ca/sunnews/specialreports/archives/2014/09/20140917-212525.html
BBC NEWS HEALTH: Call for lung cancer screening in UK
Call for lung cancer screening in UK View article here: http://www.bbc.com/news/health-29142822 Delays introducing lung cancer screening in the UK could cost thousands of lives, warns a leading cancer expert. Prof John Field of Liverpool University says planning should start now for nationwide screening of older smokers by the end of 2016. US data suggests screening […]
LUNG CANCER NEWS TODAY: New Urine Test Offers Early Lung Cancer Detection
New Urine Test Offers Early Lung Cancer Detection View article: http://lungcancernewstoday.com/2014/09/09/new-urine-test-offers-early-lung-cancer-detection/ Researchers from the University of Victoria, Canada, have devised a new test for early detection of lung cancer, using surface enhanced Raman spectroscopy (SERS) to identify a cancer biomarker present in urine. Early lung cancer detection is a difficult task, and current methods in […]
BioMark Selected for one of the 25 spots at HUB in Boston
BioMark Selected for one of the 25 spots at upcoming 48 hours at the HUB in Boston 48 hours in the Hub takes place in Cambridge, MA from October 20-22, 2014. This program is funded under the Canadian Technology Accelerator program. In preparation of the 48 hours at the HUB, BioMark visited Consul and Trade […]
BioMark Raman SenSers Product Launch
BioMark Raman SenSers Product Launch at Strategies on Biophotonics Boston September 9-11 2014 http://pubs.rsc.org/en/Content/ArticleLanding/2014/AN/c4an01309c#!divAbstract BioMark is proud to announce the launch of its first generation Raman SERS at the first Strategies in Biophotonics conference held in Boston. The technology platform was developed by Dr. Reuven and Dr. Hof from the University of Victoria, BioMark and […]
Trace cancer biomarker quantification using polystyrene-functionalized gold nanorods
For more information, visit Optics Infobase: http://www.opticsinfobase.org/boe/abstract.cfm?uri=boe-5-12-4101 Or download the following PDF: boe-5-12-4101
